Cardio Diagnostics Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cardio Diagnostics Holdings, Inc. (CDIO) on August 20, 2026. The report serves as a current disclosure regarding the commencement of the use of an Investor Presentation for communications with existing and prospective investors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding disclosure materials and does not contain financial statements or performance data.
Material Changes
Effective August 20, 2026, senior management began utilizing the materials contained in Exhibit 99.1 (the "Investor Presentation") for investor presentations. No material changes to financial operations or corporate structure are reported in this specific filing.
Guidance, Outlook, and Risks
The filing incorporates an Investor Presentation by reference but explicitly states that the information contained in Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the text does not provide specific guidance, outlook, or risk factors within the body of this report.
Key Facts for Investor Verification
- Verify the content of the Investor Presentation (Exhibit 99.1) available on the company website (www.cdio.ai) for forward-looking statements.
- Note that the presentation materials are not legally "filed" with the SEC and are not incorporated by reference into other registration statements unless expressly stated.
- Confirm the company's status as an emerging growth company, as indicated by the checkmark in the filing.
- Review the trading symbols CDIO (Common Stock) and CDIOW (Redeemable Warrants) on The Nasdaq Stock Market LLC.